Literature DB >> 8695346

Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma.

C Eng1, K A Foster, C S Healey, C Houghton, S A Gayther, L M Mulligan, B A Ponder.   

Abstract

The characteristic tumours of MEN 2 are medullary thyroid carcinoma (MTC) and phaeochromocytoma. Somatic RET mutations have been found in only 23-40% of sporadic MTC and 10% of sporadic phaeochromocytomas. Thus, we sought other genes which may play a role in the pathogenesis of these tumours. We carried out direct sequence analysis of human c-mos and human ENRB in a series of sporadic MTC and phaeochromocytomas to determine if somatic mutations in these two genes could account for some of the sporadic MEN 2-related tumours in which no RET mutations are detected. No somatic mutations were found.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8695346      PMCID: PMC2074627          DOI: 10.1038/bjc.1996.363

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas.

Authors:  P Komminoth; E K Kunz; X Matias-Guiu; O Hiort; G Christiansen; A Colomer; J Roth; P U Heitz
Journal:  Cancer       Date:  1995-08-01       Impact factor: 6.860

2.  Mutagenic analysis of functional domains of the mos proto-oncogene and identification of the sites important for MAPK activation and DNA binding.

Authors:  K Fukasawa; R Zhou; W T Matten; A J Armstrong; I Daar; M Oskarsson; B K Sathyanarayana; L Maclvor; T G Wood; G F Vande Woude
Journal:  Oncogene       Date:  1995-10-19       Impact factor: 9.867

3.  Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium.

Authors:  L M Mulligan; D J Marsh; B G Robinson; I Schuffenecker; J Zedenius; C J Lips; R F Gagel; S I Takai; W W Noll; M Fink
Journal:  J Intern Med       Date:  1995-10       Impact factor: 8.989

4.  Deletion of genes on chromosome 1 in endocrine neoplasia.

Authors:  C G Mathew; B A Smith; K Thorpe; Z Wong; N J Royle; A J Jeffreys; B A Ponder
Journal:  Nature       Date:  1987 Aug 6-12       Impact factor: 49.962

5.  Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.

Authors:  C Eng; P A Crossey; L M Mulligan; C S Healey; C Houghton; A Prowse; S L Chew; P L Dahia; J L O'Riordan; S P Toledo
Journal:  J Med Genet       Date:  1995-12       Impact factor: 6.318

6.  Mutations in the RET protooncogene in sporadic pheochromocytomas.

Authors:  N M Lindor; R Honchel; S Khosla; S N Thibodeau
Journal:  J Clin Endocrinol Metab       Date:  1995-02       Impact factor: 5.958

7.  Pheochromocytomas and C-cell thyroid neoplasms in transgenic c-mos mice: a model for the human multiple endocrine neoplasia type 2 syndrome.

Authors:  N Schulz; F Propst; M P Rosenberg; R I Linnoila; R S Paules; R Kovatch; Y Ogiso; G Vande Woude
Journal:  Cancer Res       Date:  1992-01-15       Impact factor: 12.701

8.  Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease.

Authors:  T Attié; A Pelet; P Edery; C Eng; L M Mulligan; J Amiel; L Boutrand; C Beldjord; C Nihoul-Fékété; A Munnich
Journal:  Hum Mol Genet       Date:  1995-08       Impact factor: 6.150

9.  RET mutations in exons 13 and 14 of FMTC patients.

Authors:  A Bolino; I Schuffenecker; Y Luo; M Seri; M Silengo; T Tocco; G Chabrier; C Houdent; A Murat; M Schlumberger
Journal:  Oncogene       Date:  1995-06-15       Impact factor: 9.867

10.  Function of c-mos proto-oncogene product in meiotic maturation in Xenopus oocytes.

Authors:  N Sagata; M Oskarsson; T Copeland; J Brumbaugh; G F Vande Woude
Journal:  Nature       Date:  1988-10-06       Impact factor: 49.962

View more
  4 in total

1.  Losses of chromosomes 1p and 3q are early genetic events in the development of sporadic pheochromocytomas.

Authors:  H Dannenberg; E J Speel; J Zhao; P Saremaslani; E van Der Harst; J Roth; P U Heitz; H J Bonjer; W N Dinjens; W J Mooi; P Komminoth; R R de Krijger
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation.

Authors:  F M Michiels; S Chappuis; B Caillou; A Pasini; M Talbot; R Monier; G M Lenoir; J Feunteun; M Billaud
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

Review 3.  Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.

Authors:  Hilde Dannenberg; Paul Komminoth; Winand N M Dinjens; Ernst Jan M Speel; Ronald R de Krijger
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

4.  Mutation analysis of the c-mos proto-oncogene in human ovarian teratomas.

Authors:  K A de Foy; S A Gayther; W H Colledge; S Crockett; I V Scott; M J Evans; B A Ponder
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.